B cells

Antiviral agents

New Data on COVID-19: Researchers Discover Promising Therapeutic Potential of Zapnometinib

Researchers have made a significant breakthrough in understanding the treatment of severe COVID-19, with a recent study revealing the effectiveness of the MEK inhibitor zapnometinib in reducing viral load and alleviating lung pathology in hospitalized patients. The study, conducted by researchers at Eberhard-Karls University in Tuebingen, Germany, demonstrated that zapnometinib

Atherosclerosis

Associations of Immune Cell Subsets With Coronary Artery Calcium Incidence and Progression in the Multi-Ethnic Study of Atherosclerosis

Researchers from Northwestern University Feinberg School of Medicine have published a study on the associations of immune cell subsets with longitudinal changes in subclinical coronary artery disease. The study used data from the Multi-Ethnic Study of Atherosclerosis (MESA) and examined the relationships between 28 immune cell subsets and changes in